Human extravillous trophoblasts bind but do not internalize antiphospholipid antibodies

Placenta

Volumn 42, Issue , 2016, Pages 9-16

  Viall, Chez A ^a   Chen, Qi ^a,b   Stone, Peter R ^a,c   Chamley, Lawrence W ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b FUDAN UNIVERSITY   (China)

^c Gravida: National Centre for Growth and Development   (New Zealand)

Author keywords

Antiphospholipid antibody; Extravillous trophoblast; Placenta; Pregnancy

Indexed keywords

ANTIPHOSPHOLIPID ANTIBODY ID2; ANTIPHOSPHOLIPID ANTIBODY IIC5; BETA2 GLYCOPROTEIN 1; LUPUS ANTICOAGULANT; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; HUMAN EXTRAVILLOUS TROPHOBLAST; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST; TROPHOBLAST; CELL LINE; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION;

ANTIBODIES, ANTIPHOSPHOLIPID; CELL LINE; FEMALE; HUMANS; PLACENTA; PREGNANCY; SIGNAL TRANSDUCTION; TROPHOBLASTS;

EID: 84978946940     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2016.03.011     Document Type: Article

References (47)

1. [1] Abou-Nassar, K., Carrier, M., Ramsay, T., Rodger, M.A., The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb. Res. 128:1 (2011), 77–85.
2. [2] Birdsall, M., Pattison, N., Chamley, L., Antiphospholipid antibodies in pregnancy. Aust. N. Z. J. Obstet. Gynaecol. 32:4 (1992), 328–330.
3. [3] Chighizola, C.B., Andreoli, L., de Jesus, G.R., Banzato, A., Pons-Estel, G.J., Erkan, D., The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Lupus 24:9 (2015), 980–984.
4. [4] Levy, R.A., dos Santos, F.C., de Jesús, G.R., de Jesus, N.R., Antiphospholipid antibodies and antiphospholipid syndrome during pregnancy: diagnostic concepts. Front. Immunol., 6, 2015, 205.
5. [5] Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H.W.M., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G., Krilis, S.A., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4:2 (2006), 295–306.
6. [6] Benirschke, K., Burton, G.J., Baergen, R., Pathology of the Human Placenta. 2012, Springer, Berlin.
7. [7] Fox, H., Pathology of the Placenta. 1997, W.B. Saunders, London.
8. [8] Brosens, I., Robertson, W.B., Dixon, H.G., The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93:2 (1967), 569–579.
9. [9] Mulla, M.J., Brosens, J.J., Chamley, L.W., Giles, I., Pericleous, C., Rahman, A., Joyce, S.K., Panda, B., Paidas, M.J., Abrahams, V.M., Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am. J. Reprod. Immunol. 62:2 (2009), 96–111.
10. [10] Mulla, M.J., Myrtolli, K., Brosens, J.J., Chamley, L.W., Kwak-Kim, J.Y., Paidas, M.J., Abrahams, V.M., Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. Am. J. Reprod. Immunol. 63:5 (2010), 339–348.
11. [11] Chamley, L.W., Duncalf, A.M., Mitchell, M.D., Johnson, P.M., Action of anticardiolipin and antibodies to [beta]2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352:9133 (1998), 1037–1038.
12. [12] Blank, M., Anafi, L., Zandman-Goddard, G., Krause, I., Goldman, S., Shalev, E., Cervera, R., Font, J., Fridkin, M., Thiesen, H.J., Shoenfeld, Y., The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int. Immunol. 19:7 (2007), 857–865.
13. [13] Di Simone, N., Caliandro, D., Castellani, R., Ferrazzani, S., De Carolis, S., Caruso, A., Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum. Reprod. 14:2 (1999), 489–495.
14. [14] Jovanovic, M., Bozic, M., Kovacevic, T., Radojcic, L., Petronijevic, M., Vicovac, L., Effects of anti-phospholipid antibodies on a human trophoblast cell line (HTR-8/SVneo). Acta Histochem. 112:1 (2010), 34–41.
15. [15] Katsuragawa, H., Kanzaki, H., Inoue, T., Hirano, T., Mori, T., Rote, N.S., Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol. Reprod. 56:1 (1997), 50–58.
16. [16] Sebire, N.J., Fox, H., Backos, M., Rai, R., Paterson, C., Regan, L., Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum. Reprod. 17:4 (2002), 1067–1071.
17. [17] Stone, S., Pijnenborg, R., Vercruysse, L., Poston, R., Khamashta, M.A., Hunt, B.J., Poston, L., The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 27:4–5 (2006), 457–467.
18. [18] Van Horn, J.T., Craven, C., Ward, K., Branch, D.W., Silver, R.M., Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 25:7 (2004), 642–648.
19. [19] Viall, C., Chamley, L., Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature. Autoimmun. Rev. 14:5 (2015), 446–471.
20. [20] Viall, C.A., Chen, Q., Liu, B., Hickey, A., Snowise, S., Salmon, J.E., Stone, P.R., Chamley, L.W., Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. J. Autoimmun. 47 (2013), 45–57.
21. [21] Chamley, L.W., Allen, J.L., Johnson, P.M., Synthesis of beta2 glycoprotein 1 by the human placenta. Placenta 18:5–6 (1997), 403–410.
22. [22] Chamley, L.W., Konarkowska, B., Duncalf, A.M., Mitchell, M.D., Johnson, P.M., Is interleukin-3 important in antiphospholipid antibody-mediated pregnancy failure?. Fertil. Steril. 76:4 (2001), 700–706.
23. [23] Wisløff, F., Jacobsen, E.M., Liestøl, S., Laboratory diagnosis of the antiphospholipid syndrome. Thromb. Res. 108:5–6 (2002), 263–271.
24. [24] James, J.L., Stone, P.R., Chamley, L.W., Cytotrophoblast differentiation in the first trimester of pregnancy: evidence for separate progenitors of extravillous trophoblasts and syncytiotrophoblast. Reproduction 130:1 (2005), 95–103.
25. [25] Coukos, G., Gafvels, M.E., Wisel, S., Ruelaz, E.A., Strickland, D.K., Strauss, J.F. 3rd, Coutifaris, C., Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and the 39-kd receptor-associated protein in human trophoblasts. Am. J. Pathol. 144:2 (1994), 383–392.
26. [26] Fischer, U., Birkenmeier, G., Horn, L.C., Localization of alpha(2)-macroglobulin receptor/low-density lipoprotein receptor in third-trimester human placentas: a preliminary immunohistochemical study. Gynecol. Obstet. Invest. 52:1 (2001), 22–25.
27. [27] Tsatas, D., Baker, M.S., Rice, G.E., Tissue-specific expression of the relaxed conformation of plasminogen activator inhibitor-2 and low-density lipoprotein receptor-related protein in human term gestational tissues. J. Histochem. Cytochem. 45:12 (1997), 1593–1602.
28. [28] Pengo, V., Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F., Iliceto, S., Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb. Haemost. 93:6 (2005), 1147–1152.
29. [29] Ruffatti, A., Tonello, M., Del Ross, T., Cavazzana, A., Grava, C., Noventa, F., Tona, F., Iliceto, S., Pengo, V., Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb. Haemost. 96 (2006), 337–341.
30. [30] Ruffatti, A., Tonello, M., Visentin, M.S., Bontadi, A., Hoxha, A., De Carolis, S., Botta, A., Salvi, S., Nuzzo, M., Rovere-Querini, P., Canti, V., Mosca, M., Mitic, G., Bertero, M.T., Pengo, V., Boffa, M.C., Tincani, A., Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology 50:9 (2011), 1684–1689.
31. [31] Arvieux, J., Pouzol, P., Roussel, B., Jacob, M.C., Colomb, M.G., Lupus-like anticoagulant properties of murine monoclonal antibodies to β2-glycoprotein I. Br. J. Haematol. 81:4 (1992), 568–573.
32. [32] Albert, C.R., Schlesinger, W.J., Viall, C.A., Mulla, M.J., Brosens, J.J., Chamley, L.W., Abrahams, V.M., Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function. Am. J. Reprod. Immunol. 71:2 (2014), 154–164.
33. [33] Carroll, T.Y., Mulla, M.J., Han, C.S., Brosens, J.J., Chamley, L.W., Giles, I., Pericleous, C., Rahman, A., Sfakianaki, A.K., Paidas, M.J., Abrahams, V.M., Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin. Am. J. Reprod. Immunol. 66:4 (2011), 286–296.
34. [34] Quenby, S., Mountfield, S., Cartwright, J.E., Whitley, G.S., Chamley, L., Vince, G., Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil. Steril. 83:3 (2005), 691–698.
35. [35] Willnow, T., Rohlmann, A., Horton, J., Otani, H., Braun, J.R., Hammer, R.E., Herz, J., RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 15:11 (1996), 2632–2639.
36. [36] Lundstrom, M., Orlando, R., Saedi, M., Woodward, L., Kurihara, H., Farquhar, M., Immunocytochemical and biochemical characterization of the Heymann nephritis antigenic complex in rat L2 yolk sac cells. Am. J. Pathol. 143:5 (1993), 1423–1435.
37. [37] Bu, G., Maksymovitch, E.A., Geuze, H., Schwartz, A.L., Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J. Biol. Chem. 269:47 (1994), 29874–29882.
38. [38] Czekay, R.P., Orlando, R.A., Woodward, L., Adamson, E.D., Farquhar, M.G., The expression of megalin (gp330) and LRP diverges during F9 cell differentiation. J. Cell Sci. 108:4 (1995), 1433–1441.
39. [39] Kerjaschki, D., Ullrich, R., Exner, M., Orlando, R.A., Farquhar, M.G., Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein. J. Exp. Med. 183:5 (1996), 2007–2015.
40. [40] Strickland, D.K., Ashcom, J.D., Williams, S., Battey, F., Behre, E., McTigue, K., Battey, J.F., Argraves, W.S., Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J. Biol. Chem. 266:20 (1991), 13364–13369.
41. [41] Juhlin, C., Rastad, J., Klareskog, L., Grimelius, L., Akerström, G., Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells. Am. J. Pathol. 135:2 (1989), 321–328.
42. [42] Lundgren, S., Carling, T., Hjalm, G., Juhlin, C., Rastad, J., Pihlgren, U., Rask, L., Akerstrom, G., Hellman, P., Tissue distribution of human gp330/megalin, a putative Ca2+-sensing protein. J. Histochem. Cytochem. 45:3 (1997), 383–392.
43. [43] Pantham, P., Viall, C., Chen, Q., Kleffmann, T., Print, C., Chamley, L., Antiphospholipid antibodies bind syncytiotrophoblast mitochondria and alter the proteome of extruded syncytial nuclear aggregates. Placenta 36:12 (2015), 1463–1473.
44. [44] Viall, C., Holloway, H., Chen, Q., Stone, P., Chamley, L., Development of a simple, cost-effective, semi-correlative light and electron microscopy method to allow the immunoelectron localisation of non-uniformly distributed placental proteins. Placenta 35:3 (2014), 223–227.
45. [45] Sorice, M., Longo, A., Capozzi, A., Garofalo, T., Misasi, R., Alessandri, C., Conti, F., Buttari, B., Riganò, R., Ortona, E., Valesini, G., Anti–β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 56:8 (2007), 2687–2697.
46. [46] Mulla, M.J., Salmon, J.E., Chamley, L.W., Brosens, J.J., Boeras, C.M., Kavathas, P.B., Abrahams, V.M., A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast. PLoS One, 8(6), 2013, e65237.
47. [47] Nilkaeo, A., Bhuvanath, S., Interleukin-1 modulation of human placental trophoblast proliferation. Mediat. Inflamm., 2006, 1–6 Article ID 79359.